Literature DB >> 6134624

Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG.

A Bond, M Lader, R Shrotriya.   

Abstract

Two doses of buspirone (5 and 10 mg tds), 1 dose of diazepam (5 mg tds) and placebo were administered to 8 normal subjects for a period of 8 days. Each subject received each drug in a balanced order with a minimum interval of 1 week between courses. Psychotropic effects were assessed with a battery of physiological, psychomotor and subjective tests on the first, third and last days of treatment both before the first daily dose and at 1 h and 3 h after it. Diazepam showed a characteristic profile of action producing EEG changes and psychological impairment after a single dose which were still present after a week's treatment. Such effects were minimal after buspirone. Both drugs increased subjective ratings of drowsiness but these feelings tended to decrease after a week's treatment on the clinical doses. Buspirone (10 mg tds) produced some unpleasant side-effects initially but tolerance to these invariably developed after 3 days treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134624     DOI: 10.1007/bf00609887

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Residual effects of hypnotics.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1972

Review 2.  Benzodiazepine dependence.

Authors:  H Petursson; M H Lader
Journal:  Br J Addict       Date:  1981

3.  Sedative effects on physiological and psychological measures in anxious patients.

Authors:  A J Bond; D C James; M H Lader
Journal:  Psychol Med       Date:  1974-11       Impact factor: 7.723

4.  A comparison of the psychotropic profiles of tofisopam and diazepam.

Authors:  A Bond; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Comparative effects of diazepam and buspirone on subjective feelings, psychological tests and the EEG.

Authors:  A J Bond; M H Lader
Journal:  Int Pharmacopsychiatry       Date:  1981

6.  The comparative efficacy of buspirone and diazepam in the treatment of anxiety.

Authors:  H L Goldberg; R J Finnerty
Journal:  Am J Psychiatry       Date:  1979-09       Impact factor: 18.112

  6 in total
  16 in total

1.  Preference for diazepam, but not buspirone, in moderate drinkers.

Authors:  S M Evans; R R Griffiths; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Concentrations and effects of buspirone are considerably reduced by rifampicin.

Authors:  T S Lamberg; K T Kivistö; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

3.  The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.

Authors:  D Allen; H V Curran; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Pharmacodynamic effects of buspirone and clobazam.

Authors:  C Alford; J Z Bhatti; S Curran; G McKay; I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

5.  Frequency domain source localization shows state-dependent diazepam effects in 47-channel EEG.

Authors:  C M Michel; R D Pascual-Marqui; W K Strik; T Koenig; D Lehmann
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  The interactions of ethanol with single and repeated doses of suriclone and diazepam on physiological and psychomotor functions in normal subjects.

Authors:  D Allen; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone.

Authors:  Kari Laine; Outi Ahokoski; Risto Huupponen; Jutta Hänninen; Sanna Palovaara; Jori Ruuskanen; Harry Björklund; Markku Anttila; Juha Rouru
Journal:  Eur J Clin Pharmacol       Date:  2003-10-18       Impact factor: 2.953

8.  Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.

Authors:  T Duka; B Schütt; W Krause; R Dorow; S McDonald; K Fichte
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

9.  The psychopharmacological effects of premazepam, diazepam and placebo in healthy human subjects.

Authors:  S Golombok; M Lader
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

10.  Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function.

Authors:  I Lucki; K Rickels; M A Giesecke; A Geller
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.